⌘K

Login Start Free

Home/Filings/4/0000943819-25-000116

4//SEC Filing

Farrell Michael J. 4

Accession 0000943819-25-000116

CIK 0000943819other

View on SEC.gov Company Profile

Filed

Nov 12, 7:00 PM ET

Accepted

Nov 13, 5:37 PM ET

Size

8.6 KB

Accession

0000943819-25-000116

Insider Transaction Report

Form 4

Period: 2025-11-11

Farrell Michael J.

DirectorChairman and CEO

Transactions

Tax Payment
ResMed Common Stock
2025-11-11$250.10/sh−2,231.545$558,109→ 465,634 total
Tax Payment
ResMed Common Stock
2025-11-11$250.10/sh−3,459.325$865,177→ 462,175 total
Tax Payment
ResMed Common Stock
2025-11-11$250.10/sh−2,205.697$551,645→ 459,969 total

Holdings

ResMed Common Stock
(indirect: By Trust)
2,090

Footnotes (3)

[F1]Disposition to issuer for tax withholding on vesting of Restricted Stock Units granted on 11/16/2022.
[F2]Disposition to issuer for tax withholding on vesting of Restricted Stock Units granted on 11/16/2023.
[F3]Disposition to issuer for tax withholding on vesting of Restricted Stock Units granted on 11/16/2024.

Documents

1 file

4
form4.xmlPrimary
PRIMARY DOCUMENT

Issuer

RESMED INC

CIK 0000943819

Entity typeother

Related Parties

1

filerCIK 0001485164

Filing Metadata

Form type: 4
Filed: Nov 12, 7:00 PM ET
Accepted: Nov 13, 5:37 PM ET
Size: 8.6 KB

View on SEC.gov